Pharma major Lupin Ltd on Thursday said it has  received approval from the US health regulator for its generic version of ...

A physical therapist was shocked to learn that for her, some of her crucial organs had an expiration date. With proactive ...

Lupin receives USFDA approval for its generic version of Tolvaptan tablets, indicated for autosomal dominant polycystic ...

Mumbai: Global pharma major, Lupin Limited, has received approval from the United States Food and Drug Administration (U.S.

Utah GM Justin Zanik recently celebrated the one-year anniversary of his kidney transplant and is back with the Jazz ...

BY SYLVESTER OJENAGBON Chronic kidney disease is a significant public health concern in Nigeria. Studies show its ...

Shawn Kortes, known for his philanthropic work in the community, started dialysis this year and is searching for a kidney ...

The drug, a copy of Jynarque, could add up to $200 million in annual revenue by FY26, strengthening Lupin’s foothold in ...

Tolvaptan is indicated to slow kidney function decline in adults at risk of rapidly progressing autosomal dominant polycystic ...

Tolvaptan slows down the deterioration of kidney function in adults who are at risk of rapidly progressing autosomal dominant polycystic kidney disease (ADPKD).